tiprankstipranks
Advertisement
Advertisement

GB:AZN Stock Latest News

Acting FDA head vows to block political interference, Endpoint News says
The FlyActing FDA head vows to block political interference, Endpoint News says
8h ago
AZN
BMY
AstraZeneca Advances New Fixed-Dose Cholesterol Pill Into Phase I: What Investors Should Watch
PremiumCompany Announcements
AstraZeneca Advances New Fixed-Dose Cholesterol Pill Into Phase I: What Investors Should Watch
9h ago
AZN
AstraZeneca: Late-Stage Pipeline Strength and Lung Cancer Upside Support Buy Rating and Unchanged 16,500 GBp Price Target
PremiumRatings
AstraZeneca: Late-Stage Pipeline Strength and Lung Cancer Upside Support Buy Rating and Unchanged 16,500 GBp Price Target
2d ago
AZN
SUNFLOWER Lupus Trial Puts AstraZeneca and ICON in Focus for Long‑Term Investors
PremiumCompany Announcements
SUNFLOWER Lupus Trial Puts AstraZeneca and ICON in Focus for Long‑Term Investors
2d ago
ICLR
FDA issues draft guidance to help accelerated cell, gene therapies for patients
PremiumThe Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
2d ago
AZN
BMY
AstraZeneca announces additional results from Phase III Serena-6 trial
PremiumThe FlyAstraZeneca announces additional results from Phase III Serena-6 trial
3d ago
AZN
AstraZeneca reports ‘further positive results’ from Phase 3 SERENA-6 trial
Premium
The Fly
AstraZeneca reports ‘further positive results’ from Phase 3 SERENA-6 trial
3d ago
AZN
AstraZeneca Adds Employee Scheme Shares to London Listing
Premium
Company Announcements
AstraZeneca Adds Employee Scheme Shares to London Listing
3d ago
AZN
AstraZeneca Confirms Total Voting Rights at 1.55 Billion Shares
PremiumCompany Announcements
AstraZeneca Confirms Total Voting Rights at 1.55 Billion Shares
3d ago
AZN
AIM ImmunoTech enrolls final subject in pancreatic cancer development program
PremiumThe Fly
AIM ImmunoTech enrolls final subject in pancreatic cancer development program
4d ago
AIM
AZN
AstraZeneca announces reuslts from EMERALD-3 Phase III trial of Imfinzi
PremiumThe Fly
AstraZeneca announces reuslts from EMERALD-3 Phase III trial of Imfinzi
4d ago
AZN
Analyst Reiterates Buy on AstraZeneca, Citing Dominant Oncology Portfolio and Sustained Growth Prospects
PremiumRatings
Analyst Reiterates Buy on AstraZeneca, Citing Dominant Oncology Portfolio and Sustained Growth Prospects
4d ago
AZN
AstraZeneca says CARES Phase 3 clinical program did not meet primary endpoint
PremiumThe FlyAstraZeneca says CARES Phase 3 clinical program did not meet primary endpoint
7d ago
AZN
AstraZeneca Imfinzi combination approved in the U.S.
Premium
The Fly
AstraZeneca Imfinzi combination approved in the U.S.
7d ago
AZN
AstraZeneca Wins First U.S. Immunotherapy Combo Approval in Early Bladder Cancer
Premium
Company Announcements
AstraZeneca Wins First U.S. Immunotherapy Combo Approval in Early Bladder Cancer
7d ago
AZN
AstraZeneca’s durvalumab approved in U.S. for NMIBC patients
PremiumThe Fly
AstraZeneca’s durvalumab approved in U.S. for NMIBC patients
7d ago
AZN
AstraZeneca confirms FDA approves Imfinzi combo for bladder cancer
PremiumThe Fly
AstraZeneca confirms FDA approves Imfinzi combo for bladder cancer
7d ago
AZN
FDA approves durvalumab combo for high-risk non-muscle invasive bladder cancer
PremiumThe Fly
FDA approves durvalumab combo for high-risk non-muscle invasive bladder cancer
7d ago
AZN
AstraZeneca Advances Camizestrant Combo Trial in Advanced Breast Cancer
PremiumCompany Announcements
AstraZeneca Advances Camizestrant Combo Trial in Advanced Breast Cancer
7d ago
AZN
AstraZeneca Maps Real-World Hypertension Care in Brazil: What Investors Should Watch
PremiumCompany AnnouncementsAstraZeneca Maps Real-World Hypertension Care in Brazil: What Investors Should Watch
8d ago
AZN
AstraZeneca’s Brazil Hyperkalaemia Study Builds Real‑World Data Edge for AZN Investors
Premium
Company Announcements
AstraZeneca’s Brazil Hyperkalaemia Study Builds Real‑World Data Edge for AZN Investors
8d ago
AZN
AstraZeneca’s OPTIMISE-CKD Update: What Dapagliflozin Real-World Data Could Mean for AZN Investors
Premium
Company Announcements
AstraZeneca’s OPTIMISE-CKD Update: What Dapagliflozin Real-World Data Could Mean for AZN Investors
8d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >